silybin has been researched along with Hypoxia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, W; Mu, J; Niu, X; Qian, L; Sun, M; Tian, Y; Wu, X; Xu, X; Xue, C; Yan, H; Yang, Y; Zhang, Z | 1 |
| Benada, O; Biedermann, D; Hrčková, G; Kofroňová, O; Kubašková, TM; Tumová, L | 1 |
| Furutani, Y; Hayama, E; Kawaguchi, K; Kawaguchi, N; Nakanishi, T; Tanaka, T; Yoshihara, K; Zhang, T | 1 |
| Cheng, HW; Cheng, YW; Huang, WK; Li, CH; Liao, PL; Lin, CH; Tse, LS | 1 |
| Bartels-Stringer, M; Kramers, C; Russel, FG; Verpalen, JT; Wetzels, JF | 1 |
5 other study(ies) available for silybin and Hypoxia
| Article | Year |
|---|---|
Silibinin exerts neuroprotective effects against cerebral hypoxia/reoxygenation injury by activating the GAS6/Axl pathway.
Topics: Apoptosis; Humans; Hypoxia; Hypoxia, Brain; Ischemic Stroke; Neuroprotective Agents; Silybin | 2023 |
Differential Effects of the Flavonolignans Silybin, Silychristin and 2,3-Dehydrosilybin on
Topics: Animals; Antioxidants; Hypoxia; In Vitro Techniques; Larva; Mesocestoides; Protective Agents; Silybin; Silymarin | 2018 |
Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Silybin; Treatment Outcome | 2019 |
Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway.
Topics: Angiogenesis Inhibitors; Animals; Autophagy; Blotting, Western; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Macular Degeneration; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred BN; Retinal Pigment Epithelium; Signal Transduction; Silybin; Silymarin; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2013 |
Iron chelation or anti-oxidants prevent renal cell damage in the rewarming phase after normoxic, but not hypoxic cold incubation.
Topics: 2,2'-Dipyridyl; Allopurinol; Animals; Antioxidants; Butylated Hydroxytoluene; Ethanol; Hypoxia; Iron Chelating Agents; L-Lactate Dehydrogenase; LLC-PK1 Cells; Organ Preservation; Organ Preservation Solutions; Reperfusion Injury; Rewarming; Silybin; Silymarin; Sodium Hydroxide; Swine | 2007 |